Mirtazapine for Fibromyalgia: An Effective Treatment Option?
Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder.
Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder.
Providing guidance to improve dietary behavior, which may include supplementation to achieve an optimal nutritional status, can contribute to improved control of fibromyalgia symptoms.
Improvement in fibromyalgia impact questionnaire scores was greater for combined tai chi groups.
A new blood test that uses RNA data to identify fibromyalgia has been released by IQuity.
A probable diagnosis of fibromyalgia can be indicated with 2 simple tests in chronic pain patients.
Opioid therapy was shown to improve quality of life in patients with comorbid fibromyalgia and PTSD.
Aerobic exercise appeared to benefit health-related quality of life in patients with fibromyalgia.
As a response to the opioid epidemic, clinicians may be overprescribing gabapentinoids.
Childhood adversity levels are increased in female patients with fibromyalgia and chronic pain.
Although there is currently no gold standard therapy for the treatment of fibromyalgia, a number of medications have shown modest efficacy in managing fibromyalgia-related pain, including pregabalin.